W. Mark Saltzman
W. Mark Saltzman
Professor of Biomedical Engineering, Yale University
Verified email at yale.edu - Homepage
Cited by
Cited by
Synthetic DNA delivery systems
D Luo, WM Saltzman
Nature biotechnology 18 (1), 33-37, 2000
Selective cell transplantation using bioabsorbable artificial polymers as matrices
JP Vacanti, MA Morse, WM Saltzman, AJ Domb, A Perez-Atayde, ...
Journal of pediatric surgery 23 (1), 3-9, 1988
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
CJ Cheng, R Bahal, IA Babar, Z Pincus, F Barrera, C Liu, A Svoronos, ...
Nature 518 (7537), 107-110, 2015
Poly (ethylene glycol)-conjugated PAMAM dendrimer for biocompatible, high-efficiency DNA delivery
D Luo, K Haverstick, N Belcheva, E Han, WM Saltzman
Macromolecules 35 (9), 3456-3462, 2002
Drug delivery: engineering principles for drug therapy
WM Saltzman
Oxford University Press, 2001
Enhancement of transfection by physical concentration of DNA at the cell surface
D Luo, WM Saltzman
Nature biotechnology 18 (8), 893-895, 2000
Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling
JD Roh, R Sawh-Martinez, MP Brennan, SM Jay, L Devine, DA Rao, T Yi, ...
Proceedings of the National Academy of Sciences 107 (10), 4669-4674, 2010
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
IA Babar, CJ Cheng, CJ Booth, X Liang, JB Weidhaas, WM Saltzman, ...
Proceedings of the National Academy of Sciences 109 (26), E1695-E1704, 2012
Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA
KA Woodrow, Y Cu, CJ Booth, JK Saucier-Sawyer, MJ Wood, ...
Nature materials 8 (6), 526-533, 2009
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells
MS Cartiera, KM Johnson, V Rajendran, MJ Caplan, WM Saltzman
Biomaterials 30 (14), 2790-2798, 2009
Enhanced and prolonged cross‐presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
H Shen, AL Ackerman, V Cody, A Giodini, ER Hinson, P Cresswell, ...
Immunology 117 (1), 78-88, 2006
Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain
LK Fung, MG Ewend, A Sills, EP Sipos, R Thompson, M Watts, OM Colvin, ...
Cancer research 58 (4), 672-684, 1998
Antibody diffusion in human cervical mucus
WM Saltzman, ML Radomsky, KJ Whaley, RA Cone
Biophysical journal 66 (2), 508-515, 1994
Building drug delivery into tissue engineering design
WM Saltzman, WL Olbricht
Nature Reviews Drug Discovery 1 (3), 177-186, 2002
Polymeric nanoparticles for drug delivery to the central nervous system
T Patel, J Zhou, JM Piepmeier, WM Saltzman
Advanced drug delivery reviews 64 (7), 701-705, 2012
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
J Park, PM Fong, J Lu, KS Russell, CJ Booth, WM Saltzman, TM Fahmy
Nanomedicine: Nanotechnology, Biology and Medicine 5 (4), 410-418, 2009
Controlled drug delivery system for treatment of neural disorders
BA Sabel, A Freese, WM Saltzman
US Patent 4,883,666, 1989
Biodegradable poly (amine-co-ester) terpolymers for targeted gene delivery
J Zhou, J Liu, CJ Cheng, TR Patel, CE Weller, JM Piepmeier, Z Jiang, ...
Nature materials 11 (1), 82-90, 2012
Materials for protein delivery in tissue engineering
SP Baldwin, WM Saltzman
Advanced drug delivery reviews 33 (1-2), 71-86, 1998
A holistic approach to targeting disease with polymeric nanoparticles
CJ Cheng, GT Tietjen, JK Saucier-Sawyer, WM Saltzman
Nature reviews Drug discovery 14 (4), 239-247, 2015
The system can't perform the operation now. Try again later.
Articles 1–20